Skip to main content
[Preprint]. 2023 Nov 20:rs.3.rs-3576089. [Version 1] doi: 10.21203/rs.3.rs-3576089/v1

Table 4.

Provider Responses to PRISM Pre-Implementation Assessment (N = 15)

SD/D Neutral A/SA
Item Item Statement n (%) n (%) n (%)
1 I would use MCP-Ch in my work with Chinese patients with advanced cancer 0 (0.0) 2 (13.3) 13 (86.7)
2 I believe there is a good evidence to support a meaning-centered approach to meet the psychosocial needs of Chinese patients with advanced cancer 0 (0.0) 2 (13.3) 13 (86.7)
3 My theoretical background and training lends itself well to using MCP-Ch with patients 0 (0.0) 1 (6.7) 14 (93.3)
4 I believe telehealth-delivered mental health interventions are safe and effective 1 (6.7) 3 (20.0) 11 (73.3)
5 I believe mental health interventions such as MCP-Ch can be delivered remotely to Chinese-speaking patients by monolingual English-speaking therapists via interpreters 5 (33.3) 3 (20.0) 7 (46.7)
6 Based upon my experience with the patient population, I believe Chinese patients with advanced cancer would find MCP-Ch helpful and acceptable 0 (0.0) 0 (0.0) 15 (100)
7 Based upon my experience with the patient population, I believe Chinese patients with advanced cancer would find telehealth delivery acceptable 1 (6.7) 2 (13.3) 12 (80.0)
8 Based upon my experience with the patient population, I believe Chinese patients with advanced cancer would find an interpreter-assisted, remotely delivered counseling program acceptable 4 (26.7) 2 (13.3) 9 (60.0)
9 MCP-Ch could be feasibly utilized in my practice setting 1 (6.7) 4 (26.7) 10 (66.7)
10 My supervisor/administration would support my use of MCP-Ch 1 (6.7) 4 (26.7) 10 (66.7)
11 My patients’ psychosocial needs (accounting for patient characteristics such as income, education level, acculturation level, cancer type, and current medical and/or mental health treatment) would be well met by MCP-Ch 1 (6.7) 1 (6.7) 13 (86.7)
12 Implementing MCP-Ch in my current practice setting is feasible 0 (0.0) 6 (40.0) 9 (60.0)
13 I have the resources and training I need to use MCP-Ch in my current practice setting 3 (20) 6 (40.0) 6 (40.0)
14 The current state and federal regulatory environment is conducive to delivering MCP-Ch via telehealth 0 (0.0) 6 (40.0) 9 (60.0)
15 The policies of my practice setting do not conflict with my use of MCP-Ch in clinical practice 2 (13.3) 3 (20.0) 10 (66.7)

SD/D, strongly disagree or disagree; A/SA, agree or strongly agree